Letter regarding "Clinical features, diagnosis, and survival analysis of dogs with glioma"
- PMID: 35894436
- PMCID: PMC9511095
- DOI: 10.1111/jvim.16492
Letter regarding "Clinical features, diagnosis, and survival analysis of dogs with glioma"
Comment in
-
Response to letter regarding "Clinical features, diagnosis, and survival analysis of dogs with glioma".J Vet Intern Med. 2022 Sep;36(5):1568-1569. doi: 10.1111/jvim.16488. Epub 2022 Jul 27. J Vet Intern Med. 2022. PMID: 35894421 Free PMC article. No abstract available.
Comment on
-
Clinical features, diagnosis, and survival analysis of dogs with glioma.J Vet Intern Med. 2021 Jul;35(4):1902-1917. doi: 10.1111/jvim.16199. Epub 2021 Jun 12. J Vet Intern Med. 2021. PMID: 34117807 Free PMC article.
References
-
- Moirano SJ, Dewey CW, Wright KZ, Cohen PW. Survival times in dogs with presumptive intracranial gliomas treated with oral lomustine: a comparative retrospective study (2008‐2017). Vet Comp Oncol. 2018;16:459‐466. - PubMed
-
- Van Meervenne S, Verhoeven PS, de Vos J, et al. Comparison between symptomatic treatment and lomustine supplementation in 71 dogs with intracranial, space‐occupying lesions. Vet Comp Oncol. 2014;12:67‐77. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical